GSK 2837808A
Chemical Name: 3-[[3-[(Cyclopropylamino)sulfonyl]-7-(2,4-dimethoxy-5-pyrimidinyl)-4-quinolinyl]amino]-5-(3,5-difluorophenoxy)benzoic acid
Purity: ≥98%
Biological Activity
GSK 2837808A is a potent and selective lactate dehydrogenase A and B (LDHA and LDHB) inhibitor (IC50 values are 2.6 and 43 nM for LDHA and LDHB respectively). Inhibits lactate production in selected cancer cell lines. Reduces glucose uptake and enhances mitochondrial oxygen consumption in Snu398 hepatocellular carcinoma cells. Inhibits proliferation and induces apoptosis in Snu398 cells. Inhibits transcription of histone 2B (H2B) gene in HCT116 and NCM460 cells. Cell permeable.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis.
Brighenti et al.
Biochem.Biophys.Res.Commun., 2017;485:742 -
Targeting lactate dehydrogenase-A inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells.
Xie et al.
Cell.Metab., 2014;19:795 -
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells.
Billiard et al.
Cancer Metab., 2013;1:19
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citations for GSK 2837808A
The citations listed below are publications that use Tocris products. Selected citations for GSK 2837808A include:
17 Citations: Showing 1 - 10
-
Mitochondrial pyruvate metabolism regulates the activation of quiescent adult neural stem cells.
Authors: Sylvie Et al.
Sci Adv 2023;9:eadd5220
-
Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells.
Authors: Randall S Et al.
Front Immunol 2023;14:1101433
-
A high-throughput multiparameter screen for accelerated development and optimization of soluble genetically encoded fluorescent biosensors.
Authors: David A Et al.
Nat Commun 2022;13:2919
-
Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma.
Authors: Jacqueline D Et al.
Cancer Immunol Res 2022;10:482-497
-
Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation.
Authors: Catherine A Et al.
Nat Commun 2021;12:1209
-
The distinct roles of calcium in rapid control of neuronal glycolysis and the tricarboxylic acid cycle.
Authors: Nidhi Et al.
Elife 2021;10
-
Lactate production is a prioritized feature of adipocyte metabolism.
Authors: David E Et al.
J Biol Chem 2020;295:83-98
-
Lactate production is a prioritized feature of adipocyte metabolism.
Authors: David E Et al.
J Biol Chem 2020;295:83-98
-
Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis.
Authors: Georg Et al.
Sci Rep 2020;10:21020
-
Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA.
Authors: Thongon Et al.
Cancer Metab 2018;6:1
-
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
Authors: Cascone Et al.
Cell Metab 2018;27:977
-
Lactate-activated macrophages induced aerobic glycolysis and epithelial-mesenchymal transition in breast cancer by regulation of CCL5-CCR5 axis: a positive metabolic feedback loop.
Authors: Lin Et al.
Oncotarget 2017;8:110426
-
Modification of tumour cell metabolism modulates sensitivity to Chk1 inhibitor-induced DNA damage.
Authors: Massey
Sci Rep 2017;7:40778
-
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis.
Authors: Brighenti Et al.
Biochem.Biophys.Res.Commun. 2017;485:742
-
Cytosolic malate dehydrogenase activity helps support glycolysis in actively proliferating cells and cancer.
Authors: Hanse Et al.
Oncogene 2017;36:3915
-
Neuronal Stimulation Triggers Neuronal Glycolysis and Not Lactate Uptake.
Authors: Diaz-Garcia Et al.
Cell Metab 2017;26:361
-
Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery.
Authors: Merk Et al.
Cell 2016;165:1698
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for GSK 2837808A
There are currently no reviews for this product. Be the first to review GSK 2837808A and earn rewards!
Have you used GSK 2837808A?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image